FR06C0032I2 - Formulations proteiniques - Google Patents

Formulations proteiniques

Info

Publication number
FR06C0032I2
FR06C0032I2 FR06C0032C FR06C0032C FR06C0032I2 FR 06C0032 I2 FR06C0032 I2 FR 06C0032I2 FR 06C0032 C FR06C0032 C FR 06C0032C FR 06C0032 C FR06C0032 C FR 06C0032C FR 06C0032 I2 FR06C0032 I2 FR 06C0032I2
Authority
FR
France
Prior art keywords
protein formulations
pharmaceutical formulations
osteoporosis
useful
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR06C0032C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Royalty L P 3
Original Assignee
Drug Royalty L P 3
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Royalty L P 3 filed Critical Drug Royalty L P 3
Publication of FR06C0032I1 publication Critical patent/FR06C0032I1/fr
Application granted granted Critical
Publication of FR06C0032I2 publication Critical patent/FR06C0032I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
FR06C0032C 1998-04-28 2006-10-20 Formulations proteiniques Active FR06C0032I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801495A SE9801495D0 (sv) 1998-04-28 1998-04-28 Protein formulationa
PCT/CA1999/000376 WO1999055353A2 (fr) 1998-04-28 1999-04-26 Formulations proteiniques

Publications (2)

Publication Number Publication Date
FR06C0032I1 FR06C0032I1 (fr) 2006-11-24
FR06C0032I2 true FR06C0032I2 (fr) 2007-04-27

Family

ID=20411122

Family Applications (1)

Application Number Title Priority Date Filing Date
FR06C0032C Active FR06C0032I2 (fr) 1998-04-28 2006-10-20 Formulations proteiniques

Country Status (24)

Country Link
US (1) US20050209144A1 (fr)
EP (1) EP1079803B1 (fr)
JP (2) JP4733267B2 (fr)
KR (1) KR100579872B1 (fr)
CN (1) CN1172658C (fr)
AT (1) ATE273693T1 (fr)
AU (2) AU766514B2 (fr)
BR (1) BR9909958A (fr)
CA (1) CA2329800C (fr)
CY (1) CY2006006I1 (fr)
DE (3) DE122006000057I2 (fr)
DK (1) DK1079803T3 (fr)
ES (1) ES2224637T3 (fr)
FR (1) FR06C0032I2 (fr)
HK (1) HK1041218B (fr)
IL (1) IL139320A (fr)
LU (1) LU91281I2 (fr)
NL (1) NL300243I2 (fr)
NZ (1) NZ508269A (fr)
PT (1) PT1079803E (fr)
SE (1) SE9801495D0 (fr)
SI (1) SI1079803T1 (fr)
WO (1) WO1999055353A2 (fr)
ZA (1) ZA200006040B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
WO2005014034A1 (fr) * 2003-07-14 2005-02-17 Nps Allelix Corp. Preparations stabilisees d'hormone parathyroide
CA2628945A1 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
CN102274492B (zh) * 2006-10-03 2014-11-26 半径健康公司 骨合成代谢蛋白质的药物递送方法
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2925333B1 (fr) * 2007-12-19 2012-04-13 Farid Bennis Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
JP2009091363A (ja) * 2008-11-21 2009-04-30 Asahi Kasei Pharma Kk Ｐｔｈの安定化水溶液注射剤
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
WO2012169435A1 (fr) * 2011-06-07 2012-12-13 旭化成ファーマ株式会社 Préparation pharmaceutique lyophilisée contenant du pth de pureté élevée et son procédé de production
CN103301058A (zh) * 2013-06-17 2013-09-18 深圳翰宇药业股份有限公司 一种特立帕肽注射用组合物及其制备方法和制剂
EP4039253A1 (fr) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Procédés de traitement du cancer
CN106309358A (zh) * 2015-06-29 2017-01-11 成都金凯生物技术有限公司 含有人甲状旁腺激素的药物组合物及其制备方法与用途
EP3565542B1 (fr) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Formes polymorphes de rad1901-2hcl
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物
CN108159404B (zh) * 2018-01-05 2019-08-27 北京博康健基因科技有限公司 重组人甲状旁腺激素制剂及其制备方法
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5744444A (en) * 1989-10-27 1998-04-28 Haemopep Pharma Gmbh HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
JP2662842B2 (ja) * 1991-12-09 1997-10-15 旭化成工業株式会社 パラサイロイドホルモンの安定化組成物
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
DE69332105T2 (de) * 1992-09-29 2003-03-06 Inhale Therapeutic Systems San Pulmonale abgabe von aktiven fragmenten des parathormons
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
DE19538687A1 (de) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
JP4053107B2 (ja) * 1996-02-01 2008-02-27 中外製薬株式会社 血小板減少症の予防剤および治療剤
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa

Also Published As

Publication number Publication date
NL300243I1 (nl) 2006-12-01
SE9801495D0 (sv) 1998-04-28
DE122006000057I1 (de) 2007-01-04
CA2329800A1 (fr) 1999-11-04
DE69919533T2 (de) 2005-09-08
KR100579872B1 (ko) 2006-05-12
DK1079803T3 (da) 2004-11-22
FR06C0032I1 (fr) 2006-11-24
IL139320A0 (en) 2001-11-25
JP2002512973A (ja) 2002-05-08
JP4733267B2 (ja) 2011-07-27
CN1172658C (zh) 2004-10-27
WO1999055353A3 (fr) 2000-01-13
AU2004200156A1 (en) 2004-02-12
ZA200006040B (en) 2002-01-28
AU3591699A (en) 1999-11-16
DE122006000057I2 (de) 2009-11-05
NL300243I2 (nl) 2007-02-01
WO1999055353A2 (fr) 1999-11-04
PT1079803E (pt) 2004-11-30
SI1079803T1 (en) 2005-02-28
DE69919533D1 (de) 2004-09-23
NZ508269A (en) 2003-12-19
LU91281I2 (fr) 2006-12-19
CA2329800C (fr) 2004-06-15
ES2224637T3 (es) 2005-03-01
JP2011105739A (ja) 2011-06-02
CY2006006I2 (el) 2009-11-04
IL139320A (en) 2007-06-17
KR20010052276A (ko) 2001-06-25
AU2004200156B2 (en) 2005-12-15
HK1041218A1 (en) 2002-07-05
US20050209144A1 (en) 2005-09-22
HK1041218B (zh) 2005-03-18
CN1319003A (zh) 2001-10-24
JP5753692B2 (ja) 2015-07-22
CY2006006I1 (el) 2009-11-04
EP1079803A2 (fr) 2001-03-07
BR9909958A (pt) 2000-12-26
ATE273693T1 (de) 2004-09-15
AU766514B2 (en) 2003-10-16
EP1079803B1 (fr) 2004-08-18

Similar Documents

Publication Publication Date Title
FR06C0032I2 (fr) Formulations proteiniques
YU83502A (sh) Nova farmaceutska smeša
EA200501744A1 (ru) Пептид (варианты), содержащая его композиция и лекарственный препарат для профилактики и лечения астеросклероза
BR0008059A (pt) Composições de valdecoxib
ES2170104T3 (es) Inhibidores de la produccion de proteinas de beta-amiloide.
YU7797A (sh) Kombinovana terapija za osteoporozu
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
UY27373A1 (es) Formulaciones de interferón beta-humano
PT917460E (pt) Formulacoes de ciclosporina
BR0011845A (pt) Complexo farmacêutico
WO2001083722A3 (fr) Enzymes therapeutiques, et methodes de traitement du mps-vi et de lignees de cellules en vue de l'obtention de ces enzymes par recombinaison
IT1307866B1 (it) Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento
ATE262538T1 (de) Lhrh-analoga zur behandlung der osteoporose
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих